China Resources Medical Holdings Co (FRA:1PH) 3-Year ROIIC % : 2.91% (As of Dec. 2025) — 23% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1PH China Resources Medical Holdings Co Ltd FRA:1PH
58 GF Score
Price €0.28
GF Value €0.43
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is China Resources Medical Holdings Co 3-Year ROIIC %?

China Resources Medical Holdings Co FRA:1PH +0.72% 58 3-Year ROIIC % is 2.91 as of Dec. 2025, which is 23% below its 10-year median of 3.78. GuruFocus rates FRA:1PH with a GF Score™ of 58/100 and a GF Value™ of €0.43 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 618 Healthcare Providers & Services companies, China Resources Medical Holdings Co ranks worse than 50.81% on this metric.

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. China Resources Medical Holdings Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 2.91%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for China Resources Medical Holdings Co's 3-Year ROIIC % or its related term are showing as below:

FRA:1PH's 3-Year ROIIC % is ranked worse than
50.81% of 618 companies
in the Healthcare Providers & Services industry
Industry Median: 3.37 vs FRA:1PH: 2.91

China Resources Medical Holdings Co  (FRA:1PH) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


China Resources Medical Holdings Co 3-Year ROIIC % Related Terms


China Resources Medical Holdings Co 3-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for China Resources Medical Holdings Co's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Resources Medical Holdings Co 3-Year ROIIC % Chart

China Resources Medical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.34 0.25 6.99 7.66 2.91

China Resources Medical Holdings Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.99 0.00 7.66 0.00 2.91

FRA:1PH vs HCA, THC, DVA: 3-Year ROIIC % Comparison

For the Medical Care Facilities subindustry, China Resources Medical Holdings Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Resources Medical Holdings Co 3-Year ROIIC % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Resources Medical Holdings Co's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where China Resources Medical Holdings Co's 3-Year ROIIC % falls into.


FRA:1PH
58GF Score
China Resources Medical Holdings Co Ltd FRA:1PH
3-Year ROIIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Resources Medical Holdings Co 3-Year ROIIC % Calculation

China Resources Medical Holdings Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 41.682552 (Dec. 2025) - 53.2605154 (Dec. 2022) )/( 1316.354 (Dec. 2025) - 1702.151 (Dec. 2022) )
=-11.5779634/-385.797
=3.00%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 3-Year ROIIC % →
What does a 3-Year ROIIC % of 2.91 mean?
China Resources Medical Holdings Co (FRA:1PH) has a 3-Year ROIIC % of 2.91 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on China Resources Medical Holdings Co and its competitors. This is 23% below median its historical median of 3.78. According to the industry distribution chart, China Resources Medical Holdings Co ranks #314 out of 618 companies in the Healthcare Providers & Services industry, placing it in the top 50.8%.
Is China Resources Medical Holdings Co's 3-Year ROIIC % too high?
China Resources Medical Holdings Co's current 3-Year ROIIC % of 2.91 is 23% below median its 10-year median of 3.78. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.37. China Resources Medical Holdings Co's value of 2.91 is 13.6% below this industry median. Based on the distribution chart, China Resources Medical Holdings Co ranks #314 out of 618 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, China Resources Medical Holdings Co has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's 3-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, China Resources Medical Holdings Co ranks #314 out of 618 companies for 3-Year ROIIC %. This places China Resources Medical Holdings Co in the lower half of its industry. The industry median 3-Year ROIIC % is 3.37. China Resources Medical Holdings Co's value of 2.91 is 13.6% below this benchmark. While the company's 10-year median is 3.78 vs. the industry median of 3.37, China Resources Medical Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.37, based on 618 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Resources Medical Holdings Co's current 3-Year ROIIC % of 2.91 is 13.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on China Resources Medical Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Resources Medical Holdings Co's current 3-Year ROIIC % is 2.91, which is 23% below median its own 10-year median of 3.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, China Resources Medical Holdings Co (FRA:1PH) is currently considered Possible Value Trap. The stock's GF Value™ is €0.43, compared to a current price of €0.28 — trading 34.9% below its estimated fair value. The current 3-Year ROIIC % is 2.91, which is 23% below median its 10-year median of 3.78 and 13.6% below the Healthcare Providers & Services industry median of 3.37. China Resources Medical Holdings Co's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For China Resources Medical Holdings Co (FRA:1PH), the current 3-Year ROIIC % is 2.91 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Resources Medical Holdings Co (FRA:1PH) Overvalued in 2026?

Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued. The current stock price of €0.28 is trading 34.9% below its estimated GF Value™ of €0.43. GuruFocus considers China Resources Medical Holdings Co to be Possible Value Trap.

Key valuation signals for FRA:1PH:

  • 3-Year ROIIC %: 2.91 (23% below median its 10-year median of 3.78)
  • GF Value™: €0.43 vs. price of €0.28 (34.9% below fair value)
  • GF Score™: 58/100 with 5 warning signs
  • Industry Position: 13.6% below the Healthcare Providers & Services median (#314 of 618)

No single metric tells the full story. See the FRA:1PH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Resources Medical Holdings Co Business Description

Other Exchanges 01515:Hong Kong
Address No. 9, Fuyi Street, 14th Floor, Kunlun Center Office Building, Fengtai District, Beijing, CHN, 100069
China Resources Medical Holdings Co Ltd is engaged in the provision of general healthcare services; provision of hospital management services, sale of pharmaceuticals, medical devices, and medical consumables, and provision of other services in the Chinese Mainland. The group has two operating segments: Hospital Business and Other Business. The Hospital Business segment includes outpatient business and inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services, and other ancillary services provided to participating hospitals and IOT/OT hospitals. It generates the majority of its revenue from the Hospital Business segment.
58GF Score

Get the complete analysis for FRA:1PH

3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.28
Price
€0.43
GF Value